Immunotherapy: From Advanced NSCLC to Early Stages, an Evolving Concept

Immunotherapy in lung cancer treatment is a long history paved with failures and some successes. During the last decade, the discovery of checkpoints inhibitors led to major advances in treating advanced and metastatic non-small cell lung cancer (NSCLC). Impressive data from early phase I-II studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Berghmans, Thierry, Durieux, Valérie, Hendriks, Lizza E. L., Dingemans, Anne-Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105823/
https://www.ncbi.nlm.nih.gov/pubmed/32266275
http://dx.doi.org/10.3389/fmed.2020.00090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105823/
https://www.ncbi.nlm.nih.gov/pubmed/32266275
http://dx.doi.org/10.3389/fmed.2020.00090

Ejemplares similares